The FDA has issued a recall for certain eye drops after receiving a consumer complaint.


December 26, 2024 Tags:

Systane Lubricant Eye Drops have been voluntarily recalled following a discovery of possible fungal contamination, the U.S. Food and Drug Administration (FDA) announced. The recall affects one batch of the product, specifically the Systane Lubricant Eye Drops Ultra PF, which were sold in single-use vials. The decision to recall the product was prompted by a consumer complaint about foreign material found inside one of the sealed vials.
The FDA's investigation revealed that the foreign material in question was fungal in nature, leading to the decision to pull the affected lot from the market. This fungal contamination presents a serious risk to users, especially those with weakened immune systems. If the contaminated drops are used, they could potentially cause eye infections that might result in vision loss or, in very rare cases, even be life-threatening for individuals with compromised immune systems.

Alcon Laboratories, the company responsible for manufacturing the Systane eye drops, has emphasized that there have been no reports of adverse effects or illnesses linked to the product thus far. The company reassured the public that the contamination appeared to be isolated to the single vial returned by a customer, and the recall was issued as a precautionary measure to prioritize the safety of consumers.

The affected batch of Systane eye drops comes in a 25-count package of on-the-go single-use vials. These vials have a lot number of 10101 and an expiration date of September 2025. The product was sold primarily at Publix grocery stores, which has issued a notice about the recall.

Systane eye drops are commonly used to treat dryness and irritation in the eyes, providing relief from the burning and discomfort that often accompanies dry eye symptoms. They are typically sold in small, portable vials for convenience, especially for people who need to manage their dry eye condition while on the go.

Consumers who have purchased the recalled product are urged to stop using it immediately. They can return the product to the place of purchase for a refund or replacement. The FDA also advises that anyone who has used the recalled eye drops and is experiencing symptoms, such as eye discomfort or irritation, should seek medical attention from a healthcare provider promptly.

Alcon, in response to the recall, assured that it is conducting an ongoing investigation to understand the root cause of the contamination. However, they stated that the foreign material seems to be limited to the single unit that was returned. As a result, the company took the necessary step to recall the affected batch out of an abundance of caution, ensuring that the safety and well-being of consumers remain a top priority.

The recall of Systane eye drops highlights the importance of vigilance when it comes to product safety, particularly for items that come in direct contact with sensitive areas like the eyes. While the recall seems to be isolated to a specific lot, it serves as a reminder to consumers to always check product labels and lot numbers, especially in the case of medical products.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

You may also like

Fuel Oil Spill Triggers Water Advisory in Minden Hills

A fuel oil spill in Minden Hills has prompted a drinking water advisory for residents relying on South Lake, after....

New Plant Serum Shows Faster Hair Regrowth Results

A team of scientists has developed a plant-based hair growth serum that has shown promising results in early clinical testing,....

Carfentanil Surge Sparks New U.S. Drug Crisis

A quiet life can unravel in seconds. For 36-year-old Michael Nalewaja, it did just days before Thanksgiving 2025. Living in....

From Plague to COVID: Study Reveals Persistent Inequality

A new study comparing victims of a 17th-century plague outbreak with modern-day COVID-19 cases has uncovered a striking pattern: social....

Cognitive Decline Breakthrough: Scientists Identify Single Protein and Potential Cure

A new study on cognitive decline is offering fresh hope by challenging the long-held belief that brain aging is irreversible.....

Common Antidepressant Shows Promise for Long COVID Fatigue

A widely used and affordable antidepressant may offer relief for one of the most persistent symptoms of long COVID—fatigue—according to....

COVID-19 Cicada Variant BA.3.2 Spreads Globally as Experts Monitor Mutation Risks

A new COVID-19 strain, widely referred to as the “Cicada” variant, is drawing attention as it gradually spreads across multiple....

Medication Costs Hit Black Canadians Harder, Study Finds

A new study has uncovered a troubling gap in Canada’s healthcare system: Black Canadians are significantly more likely to skip....

Meningitis B Vaccine Campaign Gains Urgency After Teen Death and Kent Outbreak

A grieving mother’s call for wider access to the meningitis B vaccine is gaining renewed attention as a recent outbreak....

P.E.I. Health Advocates Urge Ottawa to Act on Alberta’s Bill 11

Health advocates in Prince Edward Island are urging federal action against Alberta’s Bill 11, warning the controversial legislation could reshape....

COVID Still Disrupts Lives Years After Infection

For Mike Hall, life changed dramatically in the summer of 2022. What began as a COVID-19 infection for his wife....

Cancer Advocates Urge Colon Screening to Start at 45 in Canada

The Canadian Cancer Society is calling on provinces and territories to lower the starting age for colorectal cancer screening, citing....